Literature DB >> 18180356

Relationship between antibiotic use and incidence of MexXY-OprM overproducers among clinical isolates of Pseudomonas aeruginosa.

Didier Hocquet1, Arno Muller, Karine Blanc, Patrick Plésiat, Daniel Talon, Dominique Louis Monnet, Xavier Bertrand.   

Abstract

In a university hospital, time-series analysis revealed a significant relationship between antibiotic (aminoglycoside, fluoroquinolone, and cefepime) use and incidence of MexXY-OprM-overproducing Pseudomonas aeruginosa. In vitro experiments confirm that such mutants were readily selected from both PAO1 and clinical strains when grown in the presence of these antibiotics.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18180356      PMCID： PMC2258510          DOI： 10.1128/AAC.01212-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  10 in total

1.  Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXY efflux pumps simultaneously.

Authors:  Catherine Llanes; Didier Hocquet; Christelle Vogne; Dounia Benali-Baitich; Catherine Neuwirth; Patrick Plésiat
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

2.  MexAB-OprM- and MexXY-overproducing mutants are very prevalent among clinical strains of Pseudomonas aeruginosa with reduced susceptibility to ticarcillin.

Authors:  Didier Hocquet; Micheline Roussel-Delvallez; Jean-Didier Cavallo; Patrick Plésiat
Journal:  Antimicrob Agents Chemother       Date:  2007-01-12       Impact factor: 5.191

3.  Bacteriostatic and bactericidal activities of eight fluoroquinolones against MexAB-OprM-overproducing clinical strains of Pseudomonas aeruginosa.

Authors:  Philippe Dupont; Didier Hocquet; Katy Jeannot; Pascal Chavanet; Patrick Plésiat
Journal:  J Antimicrob Chemother       Date:  2005-02-18       Impact factor: 5.790

4.  Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides.

Authors:  J R Aires; T Köhler; H Nikaido; P Plésiat
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

5.  Involvement of the MexXY-OprM efflux system in emergence of cefepime resistance in clinical strains of Pseudomonas aeruginosa.

Authors:  Didier Hocquet; Patrice Nordmann; Farid El Garch; Ludovic Cabanne; Patrick Plésiat
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

6.  Use of a genetic approach to evaluate the consequences of inhibition of efflux pumps in Pseudomonas aeruginosa.

Authors:  O Lomovskaya; A Lee; K Hoshino; H Ishida; A Mistry; M S Warren; E Boyer; S Chamberland; V J Lee
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

7.  Analysis of antibiotic resistance gene expression in Pseudomonas aeruginosa by quantitative real-time-PCR.

Authors:  Jean-Luc Dumas; Christian van Delden; Karl Perron; Thilo Köhler
Journal:  FEMS Microbiol Lett       Date:  2006-01       Impact factor: 2.742

8.  Relationship between ceftriaxone use and resistance to third-generation cephalosporins among clinical strains of Enterobacter cloacae.

Authors:  A Muller; J M Lopez-Lozano; X Bertrand; D Talon
Journal:  J Antimicrob Chemother       Date:  2004-05-18       Impact factor: 5.790

9.  Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections.

Authors:  Didier Hocquet; Philippe Berthelot; Micheline Roussel-Delvallez; Roger Favre; Katy Jeannot; Odile Bajolet; Nicole Marty; Florence Grattard; Patricia Mariani-Kurkdjian; Edouard Bingen; Marie-Odile Husson; Gérard Couetdic; Patrick Plésiat
Journal:  Antimicrob Agents Chemother       Date:  2007-08-06       Impact factor: 5.191

10.  Treatment and outcome of Pseudomonas aeruginosa bacteraemia: an antibiotic pharmacodynamic analysis.

Authors:  Sheryl A Zelenitsky; Godfrey K M Harding; Siyao Sun; Kiran Ubhi; Robert E Ariano
Journal:  J Antimicrob Chemother       Date:  2003-09-01       Impact factor: 5.790
  10 in total
  18 in total

Review 1.  The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.

Authors:  Xian-Zhi Li; Patrick Plésiat; Hiroshi Nikaido
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

2.  Characterization of bacterial infections in allogeneic hematopoietic stem cell transplant recipients who received prophylactic levofloxacin with either penicillin or doxycycline.

Authors:  Bridgette L Therriault; John W Wilson; Jason N Barreto; Lynn L Estes
Journal:  Mayo Clin Proc       Date:  2010-08       Impact factor: 7.616

Review 3.  Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria.

Authors:  Hiroshi Nikaido; Jean-Marie Pagès
Journal:  FEMS Microbiol Rev       Date:  2011-07-29       Impact factor: 16.408

4.  Oxidative stress induction of the MexXY multidrug efflux genes and promotion of aminoglycoside resistance development in Pseudomonas aeruginosa.

Authors:  Sebastien Fraud; Keith Poole
Journal:  Antimicrob Agents Chemother       Date:  2010-12-20       Impact factor: 5.191

5.  Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter study.

Authors:  Gabriel Cabot; Alain A Ocampo-Sosa; Fe Tubau; María D Macia; Cristina Rodríguez; Bartolomé Moya; Laura Zamorano; Cristina Suárez; Carmen Peña; Luis Martínez-Martínez; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2011-02-28       Impact factor: 5.191

6.  Determinants of intrinsic aminoglycoside resistance in Pseudomonas aeruginosa.

Authors:  Thomas Krahn; Christie Gilmour; Justin Tilak; Sebastien Fraud; Nicholas Kerr; Calvin Ho-Fung Lau; Keith Poole
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

7.  Efflux pumps expression and its association with porin down-regulation and beta-lactamase production among Pseudomonas aeruginosa causing bloodstream infections in Brazil.

Authors:  Danilo E Xavier; Renata C Picão; Raquel Girardello; Lorena C C Fehlberg; Ana C Gales
Journal:  BMC Microbiol       Date:  2010-08-12       Impact factor: 3.605

8.  Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump.

Authors:  Katy Jeannot; Sylvie Elsen; Thilo Köhler; Ina Attree; Christian van Delden; Patrick Plésiat
Journal:  Antimicrob Agents Chemother       Date:  2008-05-12       Impact factor: 5.191

9.  Multiple mutations lead to MexXY-OprM-dependent aminoglycoside resistance in clinical strains of Pseudomonas aeruginosa.

Authors:  Sophie Guénard; Cédric Muller; Laura Monlezun; Philippe Benas; Isabelle Broutin; Katy Jeannot; Patrick Plésiat
Journal:  Antimicrob Agents Chemother       Date:  2013-10-21       Impact factor: 5.191

10.  A nonlinear time-series analysis approach to identify thresholds in associations between population antibiotic use and rates of resistance.

Authors:  José-María López-Lozano; Timothy Lawes; César Nebot; Arielle Beyaert; Xavier Bertrand; Didier Hocquet; Mamoon Aldeyab; Michael Scott; Geraldine Conlon-Bingham; David Farren; Gábor Kardos; Adina Fésűs; Jesús Rodríguez-Baño; Pilar Retamar; Nieves Gonzalo-Jiménez; Ian M Gould
Journal:  Nat Microbiol       Date:  2019-04-08       Impact factor: 17.745
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.